How a Top 20 Pharma saved ~$10M with innovative study design

A global pharma company received FDA approval for a drug to treat a chronic disease. With uptake falling short of expectations, the client wanted to publish a comparative study between the new treatment and existing alternatives.

However, enrolling patients during the pandemic with regular follow-ups was challenging and costly.

The client’s innovative study design introduced complex privacy and contractual challenges. With Privacy Analytics’ help, they were able to implement this study design with auditable proof of privacy protection, saving 35% of the cost of a traditional study (~$10M).

Read the case study to find out how.